Icu Medical Stock Performance
| ICUI Stock | USD 148.33 3.18 2.19% |
On a scale of 0 to 100, ICU Medical holds a performance score of 9. The firm retains a Market Volatility (i.e., Beta) of 0.9, which attests to possible diversification benefits within a given portfolio. ICU Medical returns are very sensitive to returns on the market. As the market goes up or down, ICU Medical is expected to follow. Please check ICU Medical's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether ICU Medical's current trending patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ICU Medical are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, ICU Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.19 | Five Day Return 1.32 | Year To Date Return (6.11) | Ten Year Return 33.5 | All Time Return 3.1 K |
Last Split Factor 3:2 | Last Split Date 2002-03-18 |
1 | Is ICU Medical, Inc. Trading At A 50 percent Discount | 10/01/2025 |
2 | Verano Holdings Corp. Reports Q3 Loss, Lags Revenue Estimates | 10/29/2025 |
3 | Disposition of 430 shares by Ben Sousa of ICU Medical subject to Rule 16b-3 | 10/31/2025 |
4 | ICUI Q3 Deep Dive Strategic Execution Drives Margin Gains Amid Revenue Headwinds | 11/07/2025 |
5 | Disposition of 930 shares by Virginia Sanzone of ICU Medical at 142.345 subject to Rule 16b-3 | 11/11/2025 |
6 | 1 Healthcare Stock with Impressive Fundamentals and 2 Facing Headwinds | 11/12/2025 |
7 | ICU Medical Is Up 6.8 percent After Narrowing 2025 Net Loss Guidance Has Operational Discipline Peaked | 11/14/2025 |
8 | ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference | 11/20/2025 |
9 | Disposition of 2897 shares by Daniel Woolson of ICU Medical at 152.3522 subject to Rule 16b-3 | 11/25/2025 |
10 | Medical Devices Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown Artivion Vs The Rest | 11/26/2025 |
11 | Comparing Futureworld and ICU Medical | 11/28/2025 |
12 | Assessing ICU Medical After a 19.4 percent Rally and Conflicting Valuation Signals | 12/03/2025 |
13 | Norges Bank Invests 36.63 Million in ICU Medical, Inc. ICUI | 12/08/2025 |
14 | ICU Medical, Inc. ICUI Shares Sold by Squarepoint Ops LLC | 12/19/2025 |
| Begin Period Cash Flow | 254.2 M | |
| Total Cashflows From Investing Activities | -89 M |
ICU Medical Relative Risk vs. Return Landscape
If you would invest 12,653 in ICU Medical on September 24, 2025 and sell it today you would earn a total of 2,180 from holding ICU Medical or generate 17.23% return on investment over 90 days. ICU Medical is currently generating 0.2766% in daily expected returns and assumes 2.2166% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than ICU, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ICU Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ICU Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ICU Medical, and traders can use it to determine the average amount a ICU Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1248
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ICUI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average ICU Medical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ICU Medical by adding it to a well-diversified portfolio.
ICU Medical Fundamentals Growth
ICU Stock prices reflect investors' perceptions of the future prospects and financial health of ICU Medical, and ICU Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ICU Stock performance.
| Return On Equity | -0.0035 | ||||
| Return On Asset | 0.0192 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 4.65 B | ||||
| Shares Outstanding | 24.69 M | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 1.69 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 2.38 B | ||||
| Gross Profit | 846.31 M | ||||
| EBITDA | 42.96 M | ||||
| Net Income | (117.69 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.64 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 86.17 X | ||||
| Cash Flow From Operations | 204.03 M | ||||
| Earnings Per Share | (0.32) X | ||||
| Market Capitalization | 3.58 B | ||||
| Total Asset | 4.2 B | ||||
| Retained Earnings | 690.16 M | ||||
| Working Capital | 885.8 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
About ICU Medical Performance
By evaluating ICU Medical's fundamental ratios, stakeholders can gain valuable insights into ICU Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ICU Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ICU Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 137.04 | 72.68 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.06) | (0.06) |
Things to note about ICU Medical performance evaluation
Checking the ongoing alerts about ICU Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ICU Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 2.38 B. Net Loss for the year was (117.69 M) with profit before overhead, payroll, taxes, and interest of 846.31 M. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: ICU Medical, Inc. ICUI Shares Sold by Squarepoint Ops LLC |
- Analyzing ICU Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ICU Medical's stock is overvalued or undervalued compared to its peers.
- Examining ICU Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ICU Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ICU Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ICU Medical's stock. These opinions can provide insight into ICU Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |